熱門資訊> 正文

Aerovate Therapeutics探索战略替代方案

2024-07-08 20:26

AEROVATE THERAPEUTICS, INC.(AVTE) 0

Aerovate Therapeutics (NASDAQ:AVTE) said it will conduct a comprehensive review of strategic alternatives.
As part of this review process, the company might explore strategic alternatives, which may include, but are not limited to, an acquisition, merger, reverse merger, business combination, liquidation or other transaction.

More on Aerovate Therapeutics

Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market
Aerovate Therapeutics slides after its hypertension treatment fails to meet main goal

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。